» Articles » PMID: 19616984

Prevalence of Feline Immunodeficiency Virus and Feline Leukaemia Virus Among Client-owned Cats and Risk Factors for Infection in Germany

Overview
Date 2009 Jul 21
PMID 19616984
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

This study was conducted to determine prevalence and risk factors for retrovirus infection of infected cats in a large cat population in Germany by evaluation of 17,462 client-owned cats that were tested for the presence of feline immunodeficiency virus (FIV) antibodies or feline leukaemia virus (FeLV) antigen. The owners of a subset of 100 cats were contacted to determine their cat's survival times. Prevalence of FIV and FeLV was 3.2% and 3.6%, respectively, remaining stable for FIV, but decreasing for FeLV (6-1%) over 10 years. Median age was 6 years in FIV- and 3 years in FeLV-infected cats. Risk factors for FIV infection were male gender, older age, mixed breed, access to outdoor, aggressive behaviour, and FeLV co-infection; and for FeLV infection contact to other cats, aggressive behaviour, and FIV co-infection. Median survival time of FIV-infected cats was not significantly different to non-infected cats, whereas FeLV-infected cats had significantly shorter median survival times than non-infected cats.

Citing Articles

Performance of a Point-of-Care Test Kit (Anigen Rapid) to Diagnose Feline Immunodeficiency Virus (FIV) Infection in Domestic Cats Using Saliva Instead of Blood in Australia.

Green J, Scannell A, Hall E, Westman M Vet Sci. 2025; 12(1).

PMID: 39852909 PMC: 11769187. DOI: 10.3390/vetsci12010035.


First Seroprevalence Study of Feline Leukemia and Feline Immunodeficiency Infections Among Cats in Algiers (Algeria) and Associated Risk Factors.

Yahiaoui F, Kardjadj M, Ben-Mahdi M Vet Sci. 2024; 11(11).

PMID: 39591320 PMC: 11598832. DOI: 10.3390/vetsci11110546.


Study of feline immunodeficiency virus prevalence and expert opinions on standards of care.

Nehring M, Dickmann E, Billington K, VandeWoude S J Feline Med Surg. 2024; 26(7):1098612X241245046.

PMID: 39073897 PMC: 11292943. DOI: 10.1177/1098612X241245046.


Evaluation of a Revised Point-of-Care Test for the Detection of Feline Leukaemia p27 Antigen and Anti-p15E Antibodies in Cats.

Giselbrecht J, Jahne S, Bergmann M, Meli M, Teichmann-Knorrn S, Zablotski Y Viruses. 2024; 16(4).

PMID: 38675954 PMC: 11054206. DOI: 10.3390/v16040614.


Epidemiological Insights into Feline Leukemia Virus Infections in an Urban Cat () Population from Brazil.

Diesel L, de Mello L, de Oliveira Santana W, Ikuta N, Fonseca A, Kipper D Animals (Basel). 2024; 14(7).

PMID: 38612290 PMC: 11010845. DOI: 10.3390/ani14071051.


References
1.
Maruyama S, Kabeya H, Nakao R, Tanaka S, Sakai T, Xuan X . Seroprevalence of Bartonella henselae, Toxoplasma gondii, FIV and FeLV infections in domestic cats in Japan. Microbiol Immunol. 2003; 47(2):147-53. DOI: 10.1111/j.1348-0421.2003.tb02798.x. View

2.
English R, Nelson P, Johnson C, Nasisse M, Tompkins W, Tompkins M . Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis. 1994; 170(3):543-52. DOI: 10.1093/infdis/170.3.543. View

3.
UELAND K, Lutz H . Prevalence of feline leukemia virus and antibodies to feline immunodeficiency virus in cats in Norway. Zentralbl Veterinarmed B. 1992; 39(1):53-8. DOI: 10.1111/j.1439-0450.1992.tb01137.x. View

4.
Pedersen N, Barlough J . Clinical overview of feline immunodeficiency virus. J Am Vet Med Assoc. 1991; 199(10):1298-305. View

5.
Calzolari M, Young E, Cox D, Davis D, Lutz H . Serological diagnosis of feline immunodeficiency virus infection using recombinant transmembrane glycoprotein. Vet Immunol Immunopathol. 1995; 46(1-2):83-92. DOI: 10.1016/0165-2427(94)07008-u. View